Successful Phase 3 study results for Ocular's Axpaxli wet AMD drug
Axpaxli

Successful Phase 3 study results for Ocular's Axpaxli wet AMD drug

Ocular Therpeutix announced successful results of their experimental drug Axpaxli in treating wet age-related macular degeneration.